Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.1.453

Lack of any Association between Blood Groups and Lung Cancer, Independent of Histology  

Oguz, Arzu (Medical Oncology Clinic, Kayseri Education and Research Hospital)
Unal, Dilek (Radiation Oncology Clinic, Kayseri Education and Research Hospital)
Tasdemir, Arzu (Pathology Clinic, Kayseri Education and Research Hospital)
Karahan, Samet (Internal Medicine Clinic, Kayseri Education and Research Hospital)
Aykas, Fatma (Internal Medicine Clinic, Kayseri Education and Research Hospital)
Mutlu, Hasan (Medical Oncology Clinic, Acibadem Hospital)
Cihan, Yasemin Benderli (Radiation Oncology Clinic, Acibadem Hospital)
Kanbay, Mehmet (Nephrology Clinic, Istanbul Medeniyet University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.1, 2013 , pp. 453-456 More about this Journal
Abstract
Introduction: Lung cancer, the leading cause of cancer deaths, is divided into 2 main classes based on its biology, therapy and prognosis: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Many cases are at an advanced stage at diagnosis, which is a major obstacle to improving outcomes. It is important to define the high risk group patients for early diagnosis and chance of cure. Blood group antigens are chemical components on erythrocyte membranes but they are also expressed on a variety of epithelial cells. Links between ABO blood groups with benign or malignant diseases, such as gastric and pancreas cancers, have been observed for a long time. In this study, we aimed to investigate any possible relationship between lung cancer histological subtypes and ABO-Rh blood groups. Materials and Methods: The files of 307 pathologically confirmed lung cancer patients were reviewed retrospectively. Cases with a serologically determined blood group and Rh factor were included and those with a history of another primary cancer were excluded, leaving a total of 221. The distribution of blood groups of the lung cancer patients were compared with the distribution of blood groups of healthy donors admitted to the Turkish Red Crescent Blood Service in our city in the year 2012. Results: There was no significant difference between patients with lung cancer of either type and the control group in terms of distribution of ABO blood groups and Rh factor (p: 0.073). There was also no relationship with non small cell cancer histological subtypes. Conclusions: In this study, we found no relationship between the ABO-Rhesus blood groups and NSCLC and SCLC groups. To our knowledge this is the first analysis of ABO blood groups in SCLC patients.
Keywords
Lung cancer; ABO blood groups; Rh factor; SCLC; NSCLC; Turkey;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Greer JB, Yazer MH, Raval JS, et al., 2010. Significant association between abo blood group and pancreatic cancer. World J Gastroenterol, 16, 5588-91.   DOI   ScienceOn
2 Hosoi E (2008). Biological and clinical aspects of ABO blood group system. J Med Invest, 55, 174-82.   DOI   ScienceOn
3 Iodice S, Maisonneuve P, Botteri E., 2010. AB0 blood group and cancer. Eur J Cancer, 46, 3345-50.   DOI   ScienceOn
4 Landsteiner K (1900). Zur Kenntnis der antifermentativen, lytischen and agglutinierenden Wirkungen des Blutserums und der Lymphe. Zentralbl Bakteriol, 27, 357-62.
5 Lee JS, Ro JY, Sahin AA, et al (1991). Expression of blood group antigen A: a favourable prognostic factor in non-small cell lung cancer. N Engl J Med, 324, 1084-90.   DOI   ScienceOn
6 Lee JS, Hong WK (1992). Prognostic factors in lung cancer. N Engl J Med, 327,47-8.   DOI   ScienceOn
7 Miyake M, Taki T, Hitomi S., 1992. Correlation of expression of H/Ley/Leb antigens with survival in patients with carcinoma of the lung. N Engl J Med, 327, 14-8.   DOI   ScienceOn
8 Reid ME, Mohandas N (2004). Red blood cell blood group antigens: structure and function. Semin Hematol, 41, 93-117.
9 Roberts TE, Hasleton P, Swindell R., 1988. Blood groups and lung cancer. Br J Cancer, 58, 278.   DOI
10 Siegel R, Ward E, Brawley O., 2011. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011, 212-36.
11 Suadicani P, Hein HO, Gyntelberg F (2007). ABO phenotypes and inflammation related predictors of lung cancer mortality: the Copenhagen Male Study-a-16 year follow up. Eur Respir J, 30, 13-20.   DOI   ScienceOn
12 Urun Y, Utkan G, Yalcin S, et al., 2012. Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal tromal tumors: Turkish Oncology Group. Asian Pac J Cancer Prev,13, 4129-31.   DOI   ScienceOn
13 Wolpin BM, Chan AT, Hartge P, et al., 2009. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 101, 424-31.   DOI   ScienceOn
14 Wolpin BM, Kraft P, Gross M, et al., 2010. Pancreatic cancer risk and ABO blood group alleles: Results from the Pancreatic Cancer Cohort Consortium. Cancer Res, 70, 1015-23.   DOI
15 Zmijewski CM (1978). Immunohematology 3rd ed.: Appleton Century Crofts New York.
16 Aberle DR, Adams AM, Berg CD, et al., 2011. Reduced lung cancer mortality with low-dose computed tomography screening. N Engl J Med, 365395-409.
17 Aird I, Bentall HH, Roberts JA (1953). A relationship between cancer of stomach and the abo blood groups. Br J Med J, 1, 799-801.   DOI
18 Dall’olio F (1996). Protein glycosylation in cancer biology: An overview. Clin Mol Pathol, 49, 126-35.   DOI
19 Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al., 2009. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet, 41, 986-90.   DOI   ScienceOn
20 Ashley DJB (1969). Blood groups and lung cancer. J Med Genet, 6, 183-6.   DOI
21 Edgren G, Hjalgrim H, Rostgaard K, et al., 2010. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol, 172, 1280-5.   DOI   ScienceOn
22 Finkelstein DM, Ettinger DS, Ruckdeschel JC (1986). Long-term survivors in metastatic non-small cell lung cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol, 4, 702-9.
23 Graziano SL, Tatum AH, Gonchoroff NJ., 1997. Blood group antigen A and flow cytometric analysis in resected early stage non-small cell lung cancer. Clin Cancer Res, 3, 87-93.